CME Group Inc. Files 8-K on Financials

Ticker: CME · Form: 8-K · Filed: 2025-02-12T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-K

Related Tickers: CME

TL;DR

CME Group filed its 8-K on Feb 12, 2025, with financial updates.

AI Summary

CME Group Inc. filed an 8-K on February 12, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The filing details the company's status as a Delaware incorporated entity with its principal executive offices located at 20 South Wacker Drive, Chicago, Illinois.

Why It Matters

This filing provides investors with updated financial information and operational results for CME Group Inc., crucial for assessing the company's performance and future outlook.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on CME Group Inc.'s results of operations and financial condition, and to provide financial statements and exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on February 12, 2025.

Where are CME Group Inc.'s principal executive offices located?

CME Group Inc.'s principal executive offices are located at 20 South Wacker Drive, Chicago, Illinois, 60606.

In which state is CME Group Inc. incorporated?

CME Group Inc. is incorporated in Delaware.

What is the Commission File Number for CME Group Inc.?

The Commission File Number for CME Group Inc. is 001-31553.

From the Filing

0001156375-25-000007.txt : 20250212 0001156375-25-000007.hdr.sgml : 20250212 20250212070559 ACCESSION NUMBER: 0001156375-25-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250212 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250212 DATE AS OF CHANGE: 20250212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 25611930 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 cme-20250212.htm 8-K cme-20250212 false 0001156375 0001156375 2025-02-12 2025-02-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   _________________________________________________________ FORM 8-K   _________________________________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 12, 2025     _________________________________________________________ CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)   _________________________________________________________   Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago Illinois   60606 (Address of Principal Executive Offices)   (Zip Code) Registrant’s telephone number, including area code: ( 312 )  930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)   ______________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock CME Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition. The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, e

View on Read The Filing